A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Mayer EL, Baurain JF, Sparano J, Strauss L, Campone M, Fumoleau P, Rugo H, Awada A, Sy O, Llombart-Cussac A

Publication

Clinical cancer research : an official journal of the American Association for Cancer Research

Publication ID (Profile URL)

https://researcherprofiles.org/profile/1486478

Publication Year

2011

PubMed ID

21903773

Publication Title

Mayer EL, Baurain JF, Sparano J, Strauss L, Campone M, Fumoleau P, Rugo H, Awada A, Sy O, Llombart-Cussac A. A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer. Clin Cancer Res. 2011 Nov 01; 17(21):6897-904.